Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

Rhea-AI Summary

Anika Therapeutics (NASDAQ: ANIK) has announced its participation in the Canaccord Genuity Musculoskeletal Conference in Las Vegas on March 7, 2023, at 3:00 p.m. PT (6:00 p.m. ET). The conference is aimed at showcasing advancements in early intervention orthopedics, a field where Anika specializes. A live audio webcast will be accessible via the Investor Relations section on Anika's official website, www.anika.com. Additionally, an audio archive of the session will be available afterward, providing further insights into the company's innovative products and strategies.

News Market Reaction – ANIK

+1.05%

+1.05% Session move

In the trading session that priced this news, ANIK gained 1.05%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEDFORD, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate at the Canaccord Genuity Musculoskeletal Conference in Las Vegas, NV on Tuesday, March 7, 2023 at 3:00 p.m. PT (6:00 p.m. ET).

A live audio webcast will be available in the Investor Relations section of Anika’s website, www.anika.com. An audio archive of the session will also be available on the website.

About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, sports medicine soft tissue repair and bone preserving joint technologies, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com

FAQ

What is Anika Therapeutics participating in on March 7, 2023?

Anika Therapeutics is participating in the Canaccord Genuity Musculoskeletal Conference.

What time will Anika Therapeutics present at the conference?

Anika Therapeutics will present at 3:00 p.m. PT (6:00 p.m. ET).

Where can I watch the Anika Therapeutics conference presentation?

The presentation will be available via a live audio webcast on Anika's Investor Relations page.

What is Anika Therapeutics known for?

Anika Therapeutics specializes in joint preservation and early intervention orthopedic care.

What products does Anika focus on?

Anika focuses on osteoarthritis pain management, regenerative solutions, and minimally invasive products.